ICON Total Long Term Liabilities 2010-2025 | ICLR
ICON total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- ICON total long term liabilities for the quarter ending March 31, 2025 were $4.533B, a 2.93% decline year-over-year.
- ICON total long term liabilities for 2024 were $4.558B, a 7.42% decline from 2023.
- ICON total long term liabilities for 2023 were $4.924B, a 17.9% decline from 2022.
- ICON total long term liabilities for 2022 were $5.997B, a 12.35% decline from 2021.
| ICON Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $4,558 |
| 2023 | $4,924 |
| 2022 | $5,997 |
| 2021 | $6,841 |
| 2020 | $461 |
| 2019 | $119 |
| 2018 | $389 |
| 2017 | $390 |
| 2016 | $386 |
| 2015 | $382 |
| 2014 | $40 |
| 2013 | $31 |
| 2012 | $34 |
| 2011 | $47 |
| 2010 | $29 |
| 2009 | $37 |
| ICON Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,533 |
| 2024-12-31 | $4,558 |
| 2024-09-30 | $4,618 |
| 2024-06-30 | $4,641 |
| 2024-03-31 | $4,670 |
| 2023-12-31 | $4,924 |
| 2023-09-30 | $5,201 |
| 2023-06-30 | $5,551 |
| 2023-03-31 | $5,734 |
| 2022-12-31 | $5,997 |
| 2022-09-30 | $6,156 |
| 2022-06-30 | $6,409 |
| 2022-03-31 | $6,552 |
| 2021-12-31 | $6,841 |
| 2021-09-30 | $7,385 |
| 2021-06-30 | $451 |
| 2021-03-31 | $452 |
| 2020-12-31 | $461 |
| 2020-09-30 | $111 |
| 2020-06-30 | $110 |
| 2020-03-31 | $118 |
| 2019-12-31 | $119 |
| 2019-09-30 | $479 |
| 2019-06-30 | $481 |
| 2019-03-31 | $473 |
| 2018-12-31 | $389 |
| 2018-09-30 | $389 |
| 2018-06-30 | $387 |
| 2018-03-31 | $386 |
| 2017-12-31 | $390 |
| 2017-09-30 | $399 |
| 2017-06-30 | $388 |
| 2017-03-31 | $395 |
| 2016-12-31 | $386 |
| 2016-09-30 | $451 |
| 2016-06-30 | $383 |
| 2016-03-31 | $387 |
| 2015-12-31 | $382 |
| 2015-09-30 | $40 |
| 2015-06-30 | $42 |
| 2015-03-31 | $47 |
| 2014-12-31 | $40 |
| 2014-09-30 | $25 |
| 2014-06-30 | $25 |
| 2014-03-31 | $24 |
| 2013-12-31 | $31 |
| 2013-09-30 | $32 |
| 2013-06-30 | $35 |
| 2013-03-31 | $36 |
| 2012-12-31 | $34 |
| 2012-09-30 | $32 |
| 2012-06-30 | $50 |
| 2012-03-31 | $53 |
| 2011-12-31 | $47 |
| 2011-09-30 | $58 |
| 2011-06-30 | $31 |
| 2011-03-31 | $30 |
| 2010-12-31 | $29 |
| 2010-09-30 | $28 |
| 2010-06-30 | $36 |
| 2010-03-31 | $37 |
| 2009-12-31 | $37 |
| 2009-09-30 | $62 |
| 2009-06-30 | $65 |
| 2009-03-31 | $93 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.234B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.286B | 26.31 |
| Elevance Health (ELV) | United States | $88.874B | 11.47 |
| CVS Health (CVS) | United States | $80.430B | 10.00 |
| Cencora (COR) | United States | $56.003B | 19.48 |
| DiDi Global (DIDIY) | China | $23.532B | 35.71 |
| Natera (NTRA) | United States | $22.361B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.999B | 0.00 |
| Solventum (SOLV) | United States | $12.948B | 13.71 |
| CochLear (CHEOY) | Australia | $11.388B | 0.00 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Revvity (RVTY) | United States | $10.841B | 18.66 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| HealthEquity (HQY) | United States | $9.646B | 42.25 |
| Avantor (AVTR) | United States | $8.906B | 12.94 |
| Medpace Holdings (MEDP) | United States | $8.522B | 22.63 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.107B | 13.93 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.135B | 24.38 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Alignment Healthcare (ALHC) | United States | $3.011B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.972B | 38.65 |
| Concentras Parent (CON) | United States | $2.824B | 16.32 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.126B | 9.06 |
| GeneDx Holdings (WGS) | United States | $2.056B | 79.20 |
| Premier (PINC) | United States | $1.889B | 14.33 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| PACS (PACS) | United States | $1.591B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.457B | 29.14 |
| Teladoc Health (TDOC) | United States | $1.275B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.210B | 9.21 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| CareDx (CDNA) | United States | $1.087B | 16.97 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.678B | 10.26 |
| LifeMD (LFMD) | United States | $0.578B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| Enhabit (EHAB) | United States | $0.547B | 45.00 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.478B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Oncology Institute (TOI) | United States | $0.248B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.058B | 0.00 |
| ModivCare (MODV) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |